Katherine Matthay

Dr. Katherine Matthay is a **Professor in the Department of Pediatrics at the UCSF School of Medicine** and the **Leader of the Pediatric Malignancies Program** in the Helen Diller Family Comprehensive Cancer Center. Her work focuses on **translational research in neuroblastoma**, with a particular emphasis on improving therapies and global oncology initiatives. She has led the **Global Neuroblastoma Network**, an international tumor board for resource-limited countries, and contributed to clinical trials and protocols for neuroblastoma treatment.

**Research Interests**: Dr. Matthay’s research spans neuroblastoma biology, therapeutic strategies, and global health. She explores mechanisms driving tumor progression, drug resistance, and the development of targeted therapies. Her global efforts include mentoring projects in Africa and Central America, and adapting treatments for low-resource settings.

**Articles**: Her recent work includes studies on Aurora Kinase A inhibition, ALK-driven therapies, and predictive biomarkers for MIBG response. These articles highlight advancements in drug combinations, molecular pathways, and global collaboration.

**Awards**: While no specific awards are listed here, her contributions to neuroblastoma research and global health are widely recognized in the field.

**Advising & Grants**: She leads large-scale clinical trials and collaborates with international teams. Her work includes optimizing response criteria and post-treatment follow-up in neuroblastoma.

**Labs/Teams**: Active in the Helen Diller Cancer Center and the Global Neuroblastoma Network, fostering multidisciplinary approaches to pediatric oncology.